(CIDRAP News) – With tougher security requirements set to take effect next April, few state public health laboratories plan to maintain stocks of certain pathogens considered most tempting to bioterrorists, according to the Association of Public Health Laboratories (APHL) and officials with state labs.
(CIDRAP News) A federal advisory committee is recommending that 11 bacterial species and viruses on the current "select agent" list, including anthrax and Ebola virus, be singled out for special safeguards and that another 19 agents be dropped from the list entirely.
(CIDRAP News) The US government needs much closer collaboration with private industrylike the arrangements used in building aircraft carriers and putting men on the moonin order to improve the nation's medical defenses against biological, chemical, radiological, and nuclear threats, says a report from a federal advisory panel.
(CIDRAP News) The Department of Health and Human Services (HHS) recently released a guide to help communities retool their health-related call centers into systems for meeting the needs of the public in homes or shelters during emergencies such as a pandemic or bioterrorist attack.
(CIDRAP News) – The US government recently awarded contracts totaling about $34 million to two companies for development of drugs to treat pneumonic plague, tularemia, and anthrax, three of the diseases terrorists are deemed most likely to try to exploit.
(CIDRAP News) – The US Department of Health and Human Services (HHS) recently unveiled its plan for developing and buying medical countermeasures against a range of biological, chemical, and other threats, with new anthrax and smallpox vaccines among the near-term priorities.
(CIDRAP News) Though the United States observed the fifth anniversary of the 2001 terrorist attacks this fall, the nation's public health emergency preparedness has improved slowly and remains inadequate, according to a report last week from the nonprofit organization Trust for America's Health (TFAH).
(CIDRAP News) The US House this week overwhelmingly approved the "BioShield" bill to guarantee a market for antidotes to biological and chemical weapons, thereby sending the legislation to President Bush for his promised signature.